Chorioamnionitis-exposure alters serum cytokine trends in premature neonates

J Perinatol. 2023 Jun;43(6):758-765. doi: 10.1038/s41372-022-01584-2. Epub 2022 Dec 20.

Abstract

Objectives: Determine if chronologic age and/or chorioamnionitis exposure alter normal serum cytokine and chemokine levels in uninfected preterm neonates during their initial NICU stay.

Study design: A 7-plex immunoassay measured levels of serum IL-1β, IL-6, IL-8, IL-10, TNF-α, CCL2, and CCL3 longitudinally from chorioamnionitis-exposed and unexposed preterm neonates under 33 weeks' gestation.

Results: Chorioamnionitis-exposed and unexposed preterm neonates demonstrated differences in the trends of IL-1β, IL-6, IL-8, IL-10, TNF-α, and CCL2 over the first month of life. The unexposed neonates demonstrated elevated levels of these inflammatory markers in the first two weeks of life with a decrease by the third week of life, while the chorioamnionitis-exposed neonates demonstrated differences over time without a predictable pattern. Chorioamnionitis-exposed and unexposed neonates demonstrated altered IL-10 and TNF-α trajectories over the first twelve weeks of life.

Conclusion: Chorioamnionitis induces a state of immune dysregulation in preterm neonates that persists beyond the immediate neonatal period.

MeSH terms

  • Chorioamnionitis*
  • Cytokines*
  • Female
  • Humans
  • Infant, Newborn
  • Interleukin-10
  • Interleukin-6
  • Interleukin-8
  • Pregnancy
  • Tumor Necrosis Factor-alpha

Substances

  • Cytokines
  • Interleukin-10
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Interleukin-8